- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/44 - Iso-indolesHydrogenated iso-indoles
Patent holdings for IPC class C07D 209/44
Total number of patents in this class: 499
10-year publication summary
|
23
|
35
|
24
|
38
|
28
|
28
|
28
|
35
|
25
|
21
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Abbvie Inc. | 1806 |
13 |
| Neophore Limited | 17 |
13 |
| Achillion Pharmaceuticals, Inc. | 164 |
10 |
| AstraZeneca AB | 2886 |
9 |
| Cognition Therapeutics, Inc. | 39 |
8 |
| Orion Corporation | 681 |
7 |
| VALO Health, Inc. | 175 |
7 |
| F. Hoffmann-La Roche AG | 7948 |
6 |
| The General Hospital Corporation | 4770 |
6 |
| Astellas Pharma Inc. | 1087 |
6 |
| Astex Therapeutics Limited | 242 |
6 |
| The Broad Institute, Inc. | 1842 |
6 |
| Mitsubishi Tanabe Pharma Corporation | 582 |
6 |
| Nerviano Medical Sciences S.r.l. | 257 |
6 |
| Taisho Pharmaceutical Co., Ltd. | 865 |
6 |
| FUJIFILM Corporation | 29696 |
5 |
| Massachusetts Institute of Technology | 10115 |
5 |
| Jiangsu Hengrui Medicine Co., Ltd. | 708 |
5 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 644 |
5 |
| The University Court of the University of Aberdeen | 121 |
5 |
| Other owners | 359 |